← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

22,016

Price

$0

Filed

Jun 23

Insider

Name

HERSHBERG ROBERT

Title

CIK

0001274139

Roles

Director

Transaction Details

Transaction Date

2025-06-18

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

73,732

Footnotes

Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 18, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer. | The shares subject to this option will vest and become exercisable on the earlier of June 18, 2026 or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.

Filing Info

Accession No.

0001601830-25-000110

Form Type

4

Issuer CIK

0001601830

HERSHBERG ROBERT's History

Date Ticker Type Value
2025-12-10 ADPT $367K
2025-11-05 ATAI A $0
2025-11-05 ATAI A $0
2025-11-05 ATAI A $0
2025-11-05 ATAI A $0
2025-09-17 HLVX U
2025-06-18 RXRX A $0
2025-06-18 RXRX A $0

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $93K 2026-04-07
Gibson Christopher $254K 2026-04-07